Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
MA Zingaropoli, P Pasculli, M Tartaglia, F Dominelli… - Biology, 2023 - mdpi.com
Simple Summary Since B cells have been linked to multiple sclerosis (MS) and its
progression as well as T cells, the second-generation anti-CD20 recombinant humanized …
progression as well as T cells, the second-generation anti-CD20 recombinant humanized …
Different roles of soluble CD40 ligand in central nervous system damage
L Du, H Chang, Y Wei, X Zhang, L Yin - Neurological Research, 2020 - Taylor & Francis
Backgroud and purpose: Soluble CD40 ligand (sCD40L) plays an important role in
inflammation and autoimmune disorders. There is still a controversy regarding sCD40L in …
inflammation and autoimmune disorders. There is still a controversy regarding sCD40L in …
Increased expression of the membrane-bound CD40 ligand on peripheral CD4+ T cells in the acute phase of AQP4-IgG-seropositive neuromyelitis optica spectrum …
J Liu, Q Zhang, Z Shi, M Yang, Z Lian, H Chen… - Journal of …, 2018 - Elsevier
Currently, no data are available regarding the expression levels of CD40L on CD4+ T cells
in patients with neuromyelitis optica spectrum disorders (NMOSD). The percentage of …
in patients with neuromyelitis optica spectrum disorders (NMOSD). The percentage of …
[HTML][HTML] Soluble Ligands of the Tumour Necrosis Factor Superfamily sTNF-α, sFas-L, sTRAIL and sCD40L in the Pathogenesis of Viliuisk encephalomyelitis
TM Sivtseva, RS Nikitina, JE Chernykh… - Opera Medica et …, 2022 - cyberleninka.ru
Viliuisk encephalomyelitis (VE) is a neurodegenerative disorder that afflicts the aboriginal
people of Yakutia in Siberia. The disease is characterized by a progressive duration and …
people of Yakutia in Siberia. The disease is characterized by a progressive duration and …